Eli Lilly weight loss drug cuts risk of developing diabetes in trial
Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with prediabetes compared with a placebo, according to initial results from a long-term study released Tuesday. The late-stage […]
Eli Lilly weight loss drug cuts risk of developing diabetes in trial Read More »